MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 200mg tablets (Milpharm Ltd) and Topamax 200mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 25mg tablets (Milpharm Ltd) and Topamax 25mg tablets (Janssen-Cilag Ltd).

Stability Notes

Original pack contains a desiccant because topiramate is hygroscopic, therefore unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Topiramate 25mg tablets (Milpharm Ltd) and Topamax 25mg tablets (Janssen-Cilag Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.